Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chetrit

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
The New England Journal of Medicine|July 28, 2001
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutationB Modan, P Hartge, G Hirsh-Yechezkel, et al.
Journal of Biomedical Informatics|October 11, 2022
Evaluation of an automated phenotyping algorithm for rheumatoid arthritisHenry W Zheng, Veena K Ranganath, Lucas C Perry, et al.
European Journal of Neurology|April 19, 2018
Application of the DAWN clinical imaging mismatch and DEFUSE 3 selection criteria: benefit seems similar but restrictive volume cut-offs might omit potential respondersC Ducroux, N Khoury, A Lecler, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2000
Immunohistochemical analyses of sporadic and familial (185delAG carriers) ovarian cancer in IsraelA Ravid, I Barshack, G Hirsh-Yechezkel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Effect of BRCA mutations on the length of survival in epithelial ovarian tumorsY Ben David, A Chetrit, G Hirsh-Yechezkel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantationR H Collins, O Shpilberg, W R Drobyski, et al.
Occupational and Environmental Medicine|June 11, 2011
Risk of brain tumours in relation to estimated RF dose from mobile phones: results from five Interphone countriesE Cardis, B K Armstrong, J D Bowman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 6, 2001
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriersW W Wang, A B Spurdle, P Kolachana, et al.
Occupational and Environmental Medicine|March 25, 2006
Validation of short term recall of mobile phone use for the Interphone studyM Vrijheid, E Cardis, B K Armstrong, et al.
Occupational and Environmental Medicine|May 26, 2009
Determinants of mobile phone output power in a multinational study: implications for exposure assessmentM Vrijheid, S Mann, P Vecchia, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|July 28, 2001
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutationB Modan, P Hartge, G Hirsh-Yechezkel, et al.
Journal of Biomedical Informatics|October 11, 2022
Evaluation of an automated phenotyping algorithm for rheumatoid arthritisHenry W Zheng, Veena K Ranganath, Lucas C Perry, et al.
European Journal of Neurology|April 19, 2018
Application of the DAWN clinical imaging mismatch and DEFUSE 3 selection criteria: benefit seems similar but restrictive volume cut-offs might omit potential respondersC Ducroux, N Khoury, A Lecler, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2000
Immunohistochemical analyses of sporadic and familial (185delAG carriers) ovarian cancer in IsraelA Ravid, I Barshack, G Hirsh-Yechezkel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Effect of BRCA mutations on the length of survival in epithelial ovarian tumorsY Ben David, A Chetrit, G Hirsh-Yechezkel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantationR H Collins, O Shpilberg, W R Drobyski, et al.
Occupational and Environmental Medicine|June 11, 2011
Risk of brain tumours in relation to estimated RF dose from mobile phones: results from five Interphone countriesE Cardis, B K Armstrong, J D Bowman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 6, 2001
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriersW W Wang, A B Spurdle, P Kolachana, et al.
Occupational and Environmental Medicine|March 25, 2006
Validation of short term recall of mobile phone use for the Interphone studyM Vrijheid, E Cardis, B K Armstrong, et al.
Occupational and Environmental Medicine|May 26, 2009
Determinants of mobile phone output power in a multinational study: implications for exposure assessmentM Vrijheid, S Mann, P Vecchia, et al.
Pageof 12